bi-1206
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
3
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Oct 1, 2016 (NCT02933320)
Timeline
2010s
- Jan 1, 2016
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
Chemistry & pharmacology
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL4594465 ↗
Also known as
- bi-1206
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04219254 | Phase 1/Phase 2 (Phase 2) | Feb 29, 2020 | BioInvent International AB, Lund University |
| NCT03571568 | Phase 1/Phase 2 (Phase 2) | May 16, 2018 | BioInvent International AB, Lund University |
| NCT02933320 | Phase 1/Phase 2 (Phase 2) | Oct 1, 2016 | Cancer Research UK |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| BioInvent International AB | For profit | 2 | 2 | 1 | 2018 |
| Lund University | Academic/Hospital | 2 | 0 | 1 | 2018 |
| Cancer Research UK | Academic/Hospital | 1 | 1 | 1 | 2016 |
3 organizations
Page 1 / 1